Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R03 CA259865
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: R01 CA262873
NCI NIH HHS
Grant: U54 CA232561
NCATS NIH HHS
Grant: UL1 TR002733
NCI NIH HHS
Grant: R21 CA195324
NCI NIH HHS
Grant: T32 CA269052
National Institutes of Health
Grant: 5UL1TR002733-02
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
National Institutes of Health
Grant: 5R01CA262873-04
Mdm2 Alternative Splicing in DNA Damage and Cancer
National Institutes of Health
Grant: 5T32CA269052-04
Training Program in Basic and Translational Pediatric Oncology Research
National Institutes of Health
Grant: 5R21CA195324-02
Targeting insulin receptor splicing for treatment of rhabdomyosarcoma
National Institutes of Health
Grant: 3U54CA232561-01A1S5
Diversity Supplement: Hernandez-Aguirre- Cripe U54
FWCI
1.11
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals